Table 1.
Description of the cohorts included in this study
| Study | N | Males (%) | Deaths | Age at inclusion (range) | Mean follow-up time (SD) |
|---|---|---|---|---|---|
| Alpha Omega Cohort | 568 | 428 (75.4%) | 157 | 69.21 (59.31–80.94) | 7.79 (2.44) |
| ALSPAC | 4351 | 0 (0%) | 17 | 47 (34–63) | 5.69 (0.01) |
| EGCUT | 10,988 | 4106 (37.4%) | 912 | 46.10 (18–103) | 7.97 (1.77) |
| ERF study | 680 | 307 (45.1%) | 107 | 50.44 (18.10–86.50) | 10.67 (2.22) |
| FINRISK 1997 cohort | 7603 | 3778 (49.7%) | 1213 | 48.29 (24.15–74.28) | 16.70 (3.23) |
| DILGOM study | 4816 | 2256 (46.8%) | 190 | 52.39 (24.06–74.18) | 7.73 (0.75) |
| KORA F4 | 1790 | 871 (48.7%) | 123 | 60.89 (32–81) | 8.02 (1.25) |
| LLS nonagenarians | 843 | 326 (38.7%) | 823 | 97.35 (89.13–109.85) | 4.03 (3.09) |
| LLS offspring + partners | 2241 | 999 (44.6%) | 191 | 70.93 (42.54–91.25) | 11.76 (1.99) |
| PROSPER | 5329 | 2583 (48.5%) | 467 | 75.30 (69.37–83.39) | 2.76 (0.53) |
| Rotterdam Study | 2963 | 1241 (41.9%) | 1254 | 75.00 (52.21–98.13) | 8.28 (3.18) |
| TwinsUK | 1996 | 0 (0%) | 58 | 64.58 (42.37–87.84) | 4.32 (2.47) |
SD standard deviation